Join to View Full Profile
3812 Stoneybrook DrDurham, NC 27705
Phone+1 919-812-4397
Fax+1 919-419-8810
Dr. Beasley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Georgia Beasley is a general surgeon in Durham, NC and is affiliated with Duke University Hospital. She received her medical degree from Duke University School of Medicine and has been in practice 9 years. She specializes in surgical oncology (other than breast) and is experienced in general / gastrointestinal surgery.
Education & Training
Duke University HospitalResidency, Surgery, 2008 - 2015
Ohio State University HospitalFellowship, Complex General Surgical Oncology, 2008 - 2015
Duke University School of MedicineClass of 2008
Certifications & Licensure
NC State Medical License 2008 - 2026
OH State Medical License 2015 - 2017
American Board of Surgery Surgery- American Board of Surgery Complex General Surgical Oncology
Clinical Trials
- PVSRIPO for Patients With Unresectable Melanoma Start of enrollment: 2018 Nov 26
- PVSRIPO in Combination With Nivolumab in Melanoma Start of enrollment: 2020 Jun 01
- Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma Start of enrollment: 2019 Dec 17
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- GLI2 Facilitates Tumor Immune Evasion and Immunotherapeutic Resistance by Coordinating WNT and Prostaglandin Signaling.Nicholas C DeVito, Y-Van Nguyen, Michael Sturdivant, Michael P Plebanek, Kaylee A Villarreal
Cancer Research. 2025-05-02 - National Trends in Management of the Nodal Basin for Pediatric Patients With Occult Stage III Melanoma in the United States.Catherine B Beckhorn, Kristen E Rhodin, Harold J Leraas, Norma E Farrow, Jay S Lee
Pediatric Blood & Cancer. 2025-05-01 - An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.Jonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, Junsung Choi, David J Eschelman
Annals of Surgical Oncology. 2025-04-07
Journal Articles
- Does the Number of Sentinel Lymph Nodes Removed Affect the False Negative Rate for Head and Neck Melanoma?Srirama Josyula, Alicia M Terando, Walter T Lee, Paul J Mosca, Charles J Puza, John H Howard, Doreen M Agnese, Georgia M Beasley, Journal of Surgical Oncology
Press Mentions
How Cancer Tumors Hijack Body’s DefensesMay 10th, 2024- Istari Oncology Announces FDA Clearance of New IND to Open LUMINOS-102: PVSRIPO with and Without Immune Checkpoint Blockade in Advanced PD-1 Refractory MelanomaNovember 16th, 2020
Grant Support
- PVSRIPO in melanomaDUKE UNIVERSITY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
